Alzheimer's Disease: Causes, Symptoms & Treatment

A guide to Alzheimer's disease - the most common cause of dementia, its stages, symptoms, and current treatments

12 min readLast updated: 2026-02-17

Quick Facts

Prevalence
~6.7 million Americans age 65+
Leading Cause
60-80% of all dementia cases
Risk Factor
Risk doubles every 5 years after age 65

What Is Alzheimer's Disease?

Alzheimer's disease is a progressive neurodegenerative disorder and the most common cause of dementia, accounting for 60 to 80% of all dementia cases. It is characterized by the gradual destruction of brain cells, leading to progressive decline in memory, thinking, behavior, and the ability to perform everyday activities. The disease typically progresses over 4 to 8 years after diagnosis, though some people live up to 20 years.

Approximately 6.7 million Americans age 65 and older are living with Alzheimer's disease. The risk increases significantly with age, roughly doubling every 5 years after age 65.

What Happens in the Brain
In Alzheimer's disease, two types of abnormal protein deposits accumulate in the brain: amyloid-beta plaques (which build up between neurons) and tau tangles (which form inside neurons). These deposits damage and eventually destroy neurons, particularly in areas responsible for memory (hippocampus) and thinking (cerebral cortex). The brain actually shrinks as the disease progresses, with significant loss of brain tissue.

Stages

Preclinical Alzheimer's (no symptoms):

  • Brain changes (amyloid buildup) begin 15-20 years before symptoms appear
  • No outward signs of cognitive decline

Mild cognitive impairment (MCI) due to Alzheimer's:

  • Noticeable memory problems greater than expected for age
  • Still able to carry out daily activities independently
  • Not all MCI progresses to Alzheimer's

Mild Alzheimer's dementia:

  • Memory lapses affecting daily life (forgetting recent events, repeating questions)
  • Difficulty with planning, organization, and problem-solving
  • Getting lost in familiar places
  • Trouble handling money and bills
  • Personality changes (withdrawal, apathy, mood changes)

Moderate Alzheimer's dementia (longest stage):

  • Increased memory loss and confusion
  • Inability to learn new things
  • Difficulty with language (finding words)
  • Problems recognizing family and friends
  • Wandering, agitation, suspiciousness
  • Needs help with daily activities (dressing, bathing)

Severe Alzheimer's dementia:

  • Loss of ability to communicate coherently
  • Complete dependence on others for care
  • Loss of awareness of surroundings
  • Difficulty swallowing
  • Loss of mobility

Risk Factors

  • Age: The strongest risk factor
  • Genetics: APOE-e4 gene variant increases risk; rare familial forms involve APP, PSEN1, or PSEN2 mutations
  • Family history: First-degree relative with Alzheimer's increases risk
  • Down syndrome: Higher risk due to extra copy of chromosome 21 (which carries the APP gene)
  • Cardiovascular risk factors: Hypertension, diabetes, high cholesterol, obesity
  • Head trauma: Especially repeated traumatic brain injuries
  • Lower education and social isolation: Less cognitive reserve
  • Hearing loss: Emerging evidence links untreated hearing loss to increased dementia risk

Diagnosis

  • Cognitive assessments: Mini-Mental State Exam (MMSE), Montreal Cognitive Assessment (MoCA)
  • Neuropsychological testing: Detailed evaluation of memory, language, executive function
  • Brain MRI: Shows brain atrophy patterns (hippocampal atrophy is characteristic)
  • PET scans: Amyloid PET or tau PET can detect protein deposits
  • Cerebrospinal fluid (CSF) analysis: Measures amyloid-beta and tau protein levels
  • Blood tests: Newer blood biomarkers (plasma amyloid, p-tau) are becoming available for screening
Clinical Note
The diagnosis of Alzheimer's disease has been transformed by biomarkers. While clinical assessment remains essential, amyloid PET imaging and CSF/blood biomarkers can now confirm Alzheimer's pathology during life with high accuracy. This is particularly important as disease-modifying treatments become available.

Treatment

There is currently no cure, but treatments can help manage symptoms and, in some cases, modestly slow progression:

Medications for cognitive symptoms:

  • Cholinesterase inhibitors (donepezil, rivastigmine, galantamine): For mild to moderate disease; modestly improve cognition and daily function
  • Memantine: For moderate to severe disease; regulates glutamate activity
  • Anti-amyloid antibodies (lecanemab, donanemab): Newer treatments that remove amyloid plaques and may slow cognitive decline in early Alzheimer's (modest but measurable benefit)

Medications for behavioral symptoms:

  • Antidepressants for depression and anxiety
  • Antipsychotics cautiously for severe agitation or psychosis (increased mortality risk in elderly)
  • Melatonin for sleep disturbances

Non-pharmacological approaches:

  • Structured daily routines
  • Cognitive stimulation and engagement
  • Physical exercise (shown to improve cognition and behavior)
  • Music therapy and art therapy
  • Caregiver education and support
  • Safety modifications in the home
Warning
Alzheimer's caregiving can be physically and emotionally exhausting. Caregivers have higher rates of depression, anxiety, and health problems. If you are caring for someone with Alzheimer's, seek support from local Alzheimer's associations, support groups, and respite care services. Taking care of yourself is essential to being able to care for your loved one.

Prevention

While there is no guaranteed way to prevent Alzheimer's, evidence supports these strategies to reduce risk:

  • Regular physical exercise (most robust evidence)
  • Cognitive engagement and lifelong learning
  • Social connection and community involvement
  • Heart-healthy diet (Mediterranean diet)
  • Adequate sleep
  • Hearing aid use when appropriate
  • Management of cardiovascular risk factors
  • Avoidance of excessive alcohol and head injuries

When to See a Doctor

See a doctor if you or a loved one experiences persistent memory problems that interfere with daily life, difficulty with familiar tasks, confusion about time or place, or personality changes. Early diagnosis allows for better planning and access to treatments.

Medically reviewed by

Medical Review Team, Neurology

Last updated: 2026-02-17Sources: 2

The content on Medical Atlas is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider.